FrancophonIA/ELRC3.0 huggingface dataset:
English: If you notice any of the side effects above, contact a doctor or the nearest hospital straight away.
Croatian: Ako primijetite bilo koju od gore navedenih nuspojava, odmah se obratite liječniku ili otiđite u najbližu bolnicu.
English: If you forget to take Segluromet
Croatian: Ako ste zaboravili uzeti Segluromet
English: • yeast infections of the penis
Croatian: • gljivične infekcije penisa
English: Therefore, symptomatic hypotension may occur after initiating Segluromet (see section 4.8), particularly in patients with impaired renal function (eGFR less than 60 ml/min/1.73 m or a CrCl less than 60 ml/min), elderly patients (≥ 65 years), patients on diuretics, or patients on anti-hypertensive therapy with a history of hypotension.
Croatian: Stoga nakon uvođenja lijeka Segluromet može doći do simptomatske hipotenzije (vidjeti dio 4.8), osobito u bolesnika s oštećenjem funkcije bubrega (eGFR manji od 60 ml/min/1,73 m2 ili CrCl manji od 60 ml/min ), starijih bolesnika (≥ 65 godina), bolesnika koji uzimaju diuretike ili bolesnika liječenih antihipertenzivima koji imaju hipotenziju u anamnezi.
English: • liver function test disorders
Croatian: • odstupanja u nalazima testova funkcije jetre
English: The risk of metformin-associated lactic acidosis increases with the patient's age because elderly patients have a greater likelihood of having hepatic, renal, or cardiac impairment than younger patients.
Croatian: Rizik od laktacidoze povezane s metforminom povećava se s dobi bolesnika jer u starijih bolesnika postoji veća vjerojatnost oštećenja funkcije jetre, bubrega ili srca nego u mlađih bolesnika.
English: 1, Blood creatinine increased/Glomerular filtration rate decreased
Croatian: 1, povišene vrijednosti kreatinina u krvi/smanjena brzina glomerularne filtracije
English: Similarly, there was no tumorigenic potential observed with metformin in male rats.
Croatian: Slično tome, u mužjaka štakora nije opažen ni tumorogeni potencijal metformina.
English: Some studies indicate that taking ertugliflozin may have contributed to an increase in cases of lower limb amputation (mainly of the toe).
Croatian: Neka ispitivanja ukazuju na to da primjena ertugliflozina može pridonijeti porastu slučajeva amputacije donjih udova (prvenstveno prsta).
English: The risk of developing diabetic ketoacidosis may be increased with prolonged fasting, excessive alcohol consumption, dehydration, sudden reductions in insulin dose, or a higher need of insulin due to major surgery or serious illness.
Croatian: Rizik od razvoja dijabetičke ketoacidoze može biti povećan kod dugotrajnog gladovanja, prekomjerne konzumacije alkohola, dehidracije, naglih smanjenja doze inzulina ili veće potrebe za inzulinom zbog velikog kirurškog zahvata ili ozbiljne bolesti,
English: Your doctor will tell you how to treat low blood sugar and what to do if you have any of the symptoms or signs below.
Croatian: Niska razina šećera u krvi (hipoglikemija; često) Liječnik će Vam reći kako liječiti niske razine šećera u krvi i što trebate učiniti ako se pojavi neki od dolje navedenih simptoma ili znakova.
English: Studies using single oral doses of metformin hydrochloride tablets 500 mg to 1,500 mg, and 850 mg to 2,550 mg, indicate that there is a lack of dose proportionality with increasing doses, which is due to decreased absorption rather than an alteration in elimination.
Croatian: Ispitivanja u kojima su se primjenjivale jednokratne peroralne doze tableta metforminklorida od 500 mg do 1500 mg te od 850 mg do 2550 mg ukazuju na izostanak proporcionalnosti dozi s povećanjem doze, što je posljedica smanjene apsorpcije, a ne izmijenjene eliminacije.
English: Patients should be assessed for ketoacidosis immediately if these symptoms occur, regardless of blood glucose level.
Croatian: Pojave li se ti simptomi, potrebno je odmah ocijeniti bolesnike kako bi se utvrdilo radi li se o ketoacidozi, neovisno o razini glukoze u krvi.
English: • take medicines that increase your urine production (diuretics) or lower blood pressure
Croatian: • ako uzimate lijekove koji povećavaju proizvodnju mokraće (diuretike) ili snižavaju krvni tlak,
English: Dehydration (losing too much water from your body; common, may affect up to 1 in 10 people) Symptoms of dehydration include:
Croatian: Dehidracija (prekomjeran gubitak tekućine iz tijela; često, može se javiti u do 1 na 10 osoba).
English: The mean systemic plasma clearance following an intravenous 100 µg dose was 11 l/hr.
Croatian: Srednja vrijednost sistemskog klirensa iz plazme nakon intravenske doze od 100 µg iznosila je 11 l/h.
English: The doctor may lower the dose of your insulin or other diabetes medicine.
Croatian: Liječnik će Vam možda smanjiti dozu inzulina ili drugih lijekova za šećernu bolest.
English: • have had a lower limb amputation.
Croatian: • ako ste imali amputaciju donjih udova.
English: The combination of ertugliflozin and sitagliptin on a background of metformin resulted in significantly greater reductions in FPG compared to sitagliptin or ertugliflozin alone.
Croatian: Kombinacija ertugliflozina i sitagliptina uz osnovno liječenje metforminom dovela je do značajno većih sniženja FPG-a nego primjena samo sitagliptina ili ertugliflozina.
English: The observed effect of food on ertugliflozin pharmacokinetics is not considered clinically relevant, and ertugliflozin may be administered with or without food.
Croatian: Opaženi učinak hrane na farmakokinetiku ertugliflozina ne smatra se klinički značajnim pa se ertugliflozin može primjenjivati s hranom ili bez nje.
English: What Segluromet contains
Croatian: Što Segluromet sadrži
English: General Segluromet should not be used in patients with type 1 diabetes mellitus.
Croatian: Općenito Segluromet se ne smije primjenjivati u bolesnika s dijabetes mellitusom tipa 1.
English: In Phase 3 clinical trials, ertugliflozin was administered without regard to meals.
Croatian: U kliničkim ispitivanjima faze 3 ertugliflozin se primjenjivao neovisno o obrocima.
English: • decreased vitamin B12 levels.
Croatian: • smanjene razine vitamina B12 u krvi.
English: • Segluromet can be used instead of taking both ertugliflozin and metformin as separate tablets.
Croatian: • Segluromet se može uzimati umjesto zasebnih tableta ertugliflozina i metformina.
English: Ertugliflozin was not mutagenic or clastogenic with or without metabolic activation in the microbial reverse mutation, in vitro cytogenetic (human lymphocytes), and in vivo rat micronucleus assays.
Croatian: Ertugliflozin nije bio mutagen ni klastogen, uz metaboličku aktivaciju ili bez nje, u testu reverzne mutacije mikroorganizama, citogenetskom testu (ljudski limfociti) in vitro i mikronukleusnom testu na štakorima in vivo.
English: The effect of Segluromet on fertility in humans has not been studied.
Croatian: Nisu ispitivani učinci lijeka Segluromet na plodnost ljudi.
English: The efficacy and safety of ertugliflozin in combination with metformin have been studied in 4 multi-centre, randomised, double-blind, placebo- and active comparator-controlled, Phase 3 clinical studies involving 3,643 patients with type 2 diabetes.
Croatian: Djelotvornost i sigurnost ertugliflozina u kombinaciji s metforminom ispitivane su u 4 multicentrična, randomizirana, dvostruko slijepa, placebom i aktivnim usporednim lijekom kontrolirana klinička ispitivanja faze 3, u kojima su sudjelovala 3643 bolesnika s dijabetesom tipa 2.
English: Genital mycotic infections (ertugliflozin)
Croatian: Genitalne gljivične infekcije (ertugliflozin)
English: • if you have liver problems.
Croatian: • ako imate tegobe s jetrom,
English: p< 0.001 compared to corresponding dose of ertugliflozin or sitagliptin (based on adjusted odds ratio comparisons from a logistic regression model using multiple imputation for missing data values).
Croatian: p < 0,001 u odnosu na odgovarajuću dozu ertugliflozina ili sitagliptina (na temelju usporedbi prilagođenih omjera izgleda iz modela logističke regresije u kojima su se koristili višestruki unosi za vrijednosti podataka koji nedostaju).
English: This decrease in ertugliflozin exposure is not considered clinically meaningful.
Croatian: To smanjenje izloženosti ertugliflozinu ne smatra se klinički značajnim.
English: In patients with type 2 diabetes treated with ertugliflozin in combination with metformin, clinically meaningful reductions in HbA1c were observed in subgroups defined by age, sex, race, ethnicity, geographic region, baseline BMI, baseline HbA1c, and duration of type 2 diabetes mellitus.
Croatian: U bolesnika s dijabetesom tipa 2 koji su liječeni ertugliflozinom u kombinaciji s metforminom, klinički značajna sniženja vrijednosti HbA1c opažena su u podskupinama definiranima prema dobi, spolu, rasi, etničkoj pripadnosti, geografskoj regiji, početnom indeksu tjelesne mase (ITM), početnoj vrijednosti HbA1c i trajanju dijabetesa mellitus tipa 2.
English: There is no clinical experience in patients with Child-Pugh class C (severe) hepatic impairment.
Croatian: Nema kliničkog iskustva s primjenom u bolesnika s oštećenjem funkcije jetre stadija C prema Child-Pugh klasifikaciji (teško oštećenje).
English: Blood creatinine increased/Glomerular filtration rate decreased and renal-related events (ertugliflozin)
Croatian: Povišene vrijednosti kreatinina u krvi/smanjena brzina glomerularne filtracije i događaji povezani s bubrezima (ertugliflozin)
English: Povidone K29-32 (E1201) Microcrystalline cellulose (E460) Crospovidone (E1202) Sodium lauryl sulfate (E487) Magnesium stearate (E470b)
Croatian: Jezgra tablete povidon K29-32 (E1201) celuloza, mikrokristalična (E460) krospovidon (E1202) natrijev laurilsulfat (E487) magnezijev stearat (E470b)
English: • excessive thirst
Croatian: • prekomjerna žeđ,
English: In in vitro studies, ertugliflozin and ertugliflozin glucuronides did not inhibit or inactivate CYPs 1A2, 2C9, 2C19, 2C8, 2B6, 2D6, or 3A4, and did not induce CYPs 1A2, 2B6, or 3A4.
Croatian: U ispitivanjima in vitro ertugliflozin i glukuronidi ertugliflozina nisu inhibirali niti inaktivirali CYP enzime 1A2, 2C9, 2C19, 2C8, 2B6, 2D6 ni 3A4 te nisu inducirali CYP enzime 1A2, 2B6 ni 3A4.
English: How Segluromet works
Croatian: Kako Segluromet djeluje
English: • You need to keep following your food and exercise plan while taking Segluromet.
Croatian: • Dok uzimate Segluromet, trebate se i dalje pridržavati svog plana prehrane i tjelovježbe.
English: The effects of a high-fat meal on the pharmacokinetics of ertugliflozin and metformin when administered as Segluromet tablets are comparable to those reported for the individual tablets.
Croatian: Učinci punomasnog obroka na farmakokinetiku ertugliflozina i metformina kada se primjenjuju u obliku Segluromet tableta usporedivi su s onima opaženima kod njihove primjene u obliku zasebnih tableta.
English: More frequent renal function monitoring is recommended in patients with a GFR below 60 ml/min.
Croatian: Preporučuje se češće praćenje funkcije bubrega u bolesnika kojima je GFR manji od 60 ml/min.
English: The primary assessment of safety was conducted in a pool of three 26-week, placebo-controlled trials.
Croatian: Objedinjeni podaci iz placebom kontroliranih ispitivanja Primarna ocjena sigurnosti provedena je na temelju objedinjenih podataka iz tri 26-tjedna placebom kontrolirana ispitivanja.
English: In the rat fertility and embryonic development study, male and female rats were administered ertugliflozin at 5, 25, and 250 mg/kg/day.
Croatian: U ispitivanju učinaka na plodnost i embrionalni razvoj na štakorima, mužjacima i ženkama štakora primijenjen je ertugliflozin u dozi od 5, 25 i 250 mg/kg na dan.
English: Food had no meaningful effect on AUCinf of ertugliflozin or metformin, but reduced mean ertugliflozin Cmax by approximately 41% and metformin Cmax by approximately 29% compared to the fasted condition.
Croatian: Hrana nije imala značajnog učinka na AUCinf ertugliflozina ni metformina, ali je smanjila srednju vrijednost Cmax ertugliflozina za približno 41% i Cmax metformina za približno 29% u odnosu na primjenu natašte.
English: Patients who may be at higher risk of DKA include patients with a low beta-cell function reserve (e.g., type 2 diabetes patients with low C-peptide or latent autoimmune diabetes in adults (LADA) or patients with a history of pancreatitis), patients with conditions that lead to restricted food intake or severe dehydration, patients for whom insulin doses are reduced and patients with increased insulin requirements due to acute medical illness, surgery, or alcohol abuse.
Croatian: Bolesnici koji bi mogli imati povećan rizik od DKA uključuju bolesnike s niskom rezervom funkcije beta-stanica (npr. bolesnici s dijabetesom tipa 2 i niskom vrijednošću C-peptida, ili s latentnim autoimunim dijabetesom u odraslih [engl. latent autoimmune diabetes in adults, LADA] ili bolesnici s pankreatitisom u anamnezi), bolesnike sa stanjima koja dovode do ograničenog unosa hrane ili teške dehidracije, bolesnike kojima su smanjene doze inzulina te bolesnike s povećanom potrebom za inzulinom zbog akutne bolesti, kirurškog zahvata ili zlouporabe alkohola.
English: Urinary glucose excretion may be associated with an increased risk of urinary tract infections.
Croatian: Izlučivanje glukoze mokraćom može biti povezano s povećanim rizikom od infekcija mokraćnih puteva.
English: • if you are taking medicines used to treat pain and inflammation (NSAID and COX-2-inhibitors,
Croatian: • ako uzimate lijekove koji se koriste za liječenje boli i upale (nesteroidne protuupalne lijekove [NSAIL] i inhibitore ciklooksigenaze-2 [COX-2], kao što su ibuprofen i celekoksib),
English: Based on results from animal studies, ertugliflozin may affect renal development and maturation (see section 5.3).
Croatian: Prema rezultatima iz ispitivanja na životinjama, ertugliflozin može utjecati na razvoj i sazrijevanje bubrega (vidjeti dio 5.3).
English: There were no additional adverse reactions identified in the pooling of these two placebo-controlled trials that included metformin relative to the three placebo-controlled studies with ertugliflozin (see below).
Croatian: U objedinjenim podacima iz ta dva placebom kontrolirana ispitivanja koja su uključivala metformin nisu prepoznate dodatne nuspojave u odnosu na one zabilježene u tri placebom kontrolirana ispitivanja ertugliflozina (vidjeti u nastavku).
English: • in patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
Croatian: • u bolesnika koji se već liječe kombinacijom ertugliflozina i metformina u zasebnim tabletama.
English: Removal of ertugliflozin by haemodialysis has not been studied.
Croatian: Uklanjanje ertugliflozina hemodijalizom nije se ispitivalo.
English: Table 5: Results at Week 52 from an active-controlled study comparing ertugliflozin to glimepiride as add-on therapy in patients inadequately controlled on metformin*
Croatian: Tablica 5: Rezultati u 52. tjednu iz aktivnim lijekom kontroliranog ispitivanja u kojem se ertugliflozin uspoređivao s glimepiridom kao dodatna terapija u bolesnika koji nisu odgovarajuće regulirani metforminom*
English: Intravascular administration of iodinated contrast agents may lead to contrast-induced nephropathy, resulting in metformin accumulation and an increased risk of lactic acidosis.
Croatian: Intravaskularna primjena jodiranih kontrastnih sredstava može dovesti do nefropatije izazvane kontrastom, što dovodi do nakupljanja metformina i povećanog rizika od laktacidoze.
English: Before initiating Segluromet, factors in the patient history that may predispose to ketoacidosis should be considered.
Croatian: Prije uvođenja lijeka Segluromet potrebno je u bolesnikovoj anamnezi razmotriti čimbenike koji bi mogli stvoriti predispoziciju za ketoacidozu.
English: †, 95% CI) * N includes all randomised, treated patients who had at least one measurement of the outcome variable.
Croatian: †, 95% CI) * N vrijednost uključuje sve randomizirane i liječene bolesnike kojima je varijabla ishoda izmjerena najmanje jednom.
English: The major metabolic pathway for ertugliflozin is UGT1A9 and UGT2B7-mediated O-glucuronidation to two glucuronides that are pharmacologically inactive at clinically relevant concentrations.
Croatian: Glavni put metabolizma ertugliflozina je O-glukuronidacija posredovana enzimima UGT1A9 i UGT2B7, kojom nastaju dva glukuronida koja su farmakološki inaktivna pri klinički značajnim koncentracijama.
English: Determination of foetal concentrations demonstrated a partial placental barrier to metformin.
Croatian: Određivanje koncentracija lijeka u fetusa pokazalo je da metformin djelomično prolazi kroz placentarnu barijeru.
English: Initiation is not recommended in patients with a glomerular filtration rate less than 60 ml/min (see section 4.4).
Croatian: Ne preporučuje se uvođenje u bolesnika kojima je brzina glomerularne filtracije manja od 60 ml/min (vidjeti dio 4.4).
English: Segluromet combines two antihyperglycaemic agents with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: ertugliflozin, a SGLT2 inhibitor, and metformin hydrochloride, a member of the biguanide class.
Croatian: Segluromet je kombinacija dva antihiperglikemijska lijeka s komplementarnim mehanizmima djelovanja, koji poboljšavaju regulaciju glikemije u bolesnika s dijabetesom tipa 2: ertugliflozina, koji je inhibitor SGLT2, i metforminklorida, lijeka iz skupine bigvanida.
English: Ertugliflozin and ertugliflozin glucuronides did not inhibit the activity of UGTs 1A6, 1A9 or 2B7 in vitro.
Croatian: Ertugliflozin i glukuronidi ertugliflozina nisu inhibirali aktivnost UGT enzima 1A6, 1A9 ni 2B7 in vitro.
English: Least squares means adjusted for treatment, time, prior antihyperglycaemic medication (metformin monotherapy or metformin + another AHA), baseline eGFR (continuous), menopausal status randomisation stratum (men, premenopausal women, women who are perimenopausal or < 3 years postmenopausal, women who are  3 years postmenopausal) and the interaction of time by treatment.
Croatian: Srednje vrijednosti prema metodi najmanjih kvadrata prilagođene za liječenje, vrijeme, prethodne antihiperglikemike (monoterapija metforminom ili metformin + drugi antihiperglikemik), početni eGFR (kontinuirani), randomizacijski stratum utemeljen na menopauzalnom statusu (muškarci, žene u predmenopauzi, žene u perimenopauzi ili žene u postmenopauzi < 3 godine te žene u postmenopauzi  3 godine) te interakciju vrijeme x liječenje.
English: • if you drink alcohol to excess (either regularly or from time to time).
Croatian: • ako prekomjerno pijete alkohol (bilo redovito ili samo povremeno) Nemojte uzimati Segluromet ako se bilo što od navedenoga odnosi na Vas.
English: In patients tolerating a total daily dose of ertugliflozin 5 mg, the dose can be increased to a total daily dose of ertugliflozin 15 mg if additional glycaemic control is needed.
Croatian: U bolesnika koji dobro podnose ukupnu dnevnu dozu ertugliflozina od 5 mg, doza se može povećati do ukupne dnevne doze ertugliflozina od 15 mg ako je potrebna dodatna regulacija glikemije.
English: 30x1 film-coated tablets
Croatian: 30 x 1 filmom obložena tableta
English: 49 film-coated tablets.
Croatian: 49 filmom obloženih tableta.
English: Coadministration of simvastatin with ertugliflozin resulted in a 24% and 19% increase in AUC and Cmax of simvastatin, respectively, and 30% and 16% increase in AUC and Cmax of simvastatin acid,
Croatian: Istodobna primjena simvastatina i ertugliflozina povisila je AUC i Cmax simvastatina za 24% odnosno 19%, dok su se AUC i Cmax simvastatinske kiseline povećali za 30% odnosno 16%.
English: Increases in serum creatinine and decreases in eGFR were greater in patients with moderate renal impairment (see section 4.8).
Croatian: Povišenja vrijednosti kreatinina u serumu i smanjenja eGFR-a bila su veća u bolesnika s umjerenim oštećenjem funkcije bubrega (vidjeti dio 4.8).
English: • take other diabetes medicines; you are more likely to get low blood sugar with certain medicines.
Croatian: • ako uzimate druge lijekove za šećernu bolest; kod primjene određenih lijekova postoji veća vjerojatnost da razina šećera u krvi postane preniska,
English: The mechanism for the small increases in simvastatin and simvastatin acid is unknown and is not perpetrated through OATP inhibition by ertugliflozin.
Croatian: Mehanizam tih malih povećanja vrijednosti AUC-a i Cmax simvastatina i simvastatinske kiseline nije poznat i nije posljedica inhibicije polipeptidnih prijenosnika organskih aniona (engl. organic anion transporting polypeptides, OATP) ertugliflozinom.
English: Administration of ertugliflozin with a high-fat and high-calorie meal decreases ertugliflozin Cmax by 29% and prolongs Tmax by 1 hour, but does not alter AUC as compared with the fasted state.
Croatian: Primjena ertugliflozina uz punomastan i visokokaloričan obrok snižava Cmax ertugliflozina za 29% i produljuje Tmax za približno 1 sat, ali ne mijenja AUC u usporedbi s primjenom natašte.
English: You should notify your doctor immediately if you notice any wounds or discolouration, or if you experience any tenderness or pain in your feet.
Croatian: Odmah obavijestite svog liječnika ako primijetite bilo kakve rane ili promjenu boje stopala ili ako su Vam stopala osjetljiva na dodir ili bolna.
English: Active-controlled study of ertugliflozin versus glimepiride as add-on combination therapy with metformin
Croatian: Aktivnim lijekom kontrolirano ispitivanje ertugliflozina naspram glimepirida kao dodatka metforminu u kombiniranoj terapiji
English: • blood tests may show changes in the amount of urea in your blood
Croatian: • nalazi krvnih pretraga mogu pokazivati promjene u količini ureje u krvi
English: In patients with decreased renal function, the plasma and blood half-life of metformin is prolonged and the renal clearance is decreased in proportion to the decrease in eGFR (see sections 4.3 and 4.4).
Croatian: U bolesnika sa smanjenom funkcijom bubrega, poluvijek metformina u plazmi i krvi je produljen, dok se bubrežni klirens smanjuje proporcionalno smanjenju eGFR-a (vidjeti dijelove 4.3 i 4.4).
English: What Segluromet is
Croatian: Što je Segluromet
English: When ertugliflozin was added to metformin and compared to sulphonylurea, the incidence of hypoglycaemia was higher for the sulphonylurea (27%) compared to ertugliflozin (5.6% and 8.2% for ertugliflozin 5 mg and 15 mg, respectively).
Croatian: Kada se ertugliflozin primjenjivao kao dodatak metforminu i uspoređivao sa sulfonilurejom, incidencija hipoglikemije bila je viša uz sulfonilureju (27%) nego uz ertugliflozin (5,6% uz ertugliflozin u dozi od 5 mg odnosno 8,2% uz ertugliflozin u dozi od 15 mg).
English: Effects on bone (shorter femur length, increased trabecular bone in the femur) as well as effects of delayed puberty were observed at an exposure 817 times the MHRD of 15 mg/day based on AUC.
Croatian: Učinci na kosti (kraći femur, povećanje trabekularne kosti u femuru) kao i učinci zakašnjelog puberteta opaženi su pri razinama izloženosti koje su bile 817 puta veće od izloženosti u ljudi pri maksimalnoj preporučenoj dozi za ljude od 15 mg na dan na temelju AUC-a.
English: Ertugliflozin did not adversely affect developmental outcomes in rats and rabbits at maternal exposures that were 239 and 1,069 times, respectively, the human exposure at the maximum clinical dose of 15 mg/day, based on AUC.
Croatian: Ertugliflozin nije štetno utjecao na ishode razvoja u štakora i kunića pri razinama izloženosti majki koje su bile 239 odnosno 1069 puta veće od izloženosti u ljudi pri maksimalnoj kliničkoj dozi od 15 mg na dan, na temelju AUC-a.
English: Limited data from clinical trials suggest that DKA occurs with common frequency when patients with type 1 diabetes are treated with SGLT2 inhibitors.
Croatian: Ograničeni podaci iz kliničkih ispitivanja ukazuju na to da je učestalost DKA česta u bolesnika s dijabetesom tipa 1 koji se liječe inhibitorima SGLT2.
English: • blood tests may show changes related to kidney function (such as ‘creatinine')
Croatian: • nalazi krvnih pretraga mogu pokazivati promjene povezane s funkcijom bubrega (poput razina